Amworld Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.50 M
as on 03-01-2025
- Revenue -50.41%
(FY 2020)
- Profit -2795.38%
(FY 2020)
- Ebitda -356.96%
(FY 2020)
- Net Worth -8301.01%
(FY 2020)
- Total Assets -20.72%
(FY 2020)
About Amworld Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Bashir Mulla, Abhay Singh, Sunil Borase, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304MH2017PTC289177
- Company No.
289177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Amworld Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bashir Mulla  | Director | 02-Jan-2017 | Current |
| Abhay Singh | Director | 02-Jan-2017 | Current |
| Sunil Borase | Director | 12-Sep-2019 | Current |
| Piyush Agrawal | Director | 12-Sep-2019 | Current |
Financial Performance of Amworld Biotech.
Amworld Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 50.41% decrease. The company also saw a substantial fall in profitability, with a 2795.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 8301.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amworld Biotech?
In 2019, Amworld Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amworld Pharmaceutical Private LimitedActive 10 months 15 daysBashir Mulla, Sunil Borase and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Mar 2017 | ₹2.50 M | Open |
How Many Employees Work at Amworld Biotech?
Amworld Biotech has a workforce of 21 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amworld Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amworld Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
